期刊文献+

冷沉淀在妇产科的应用研究 被引量:4

暂未订购
导出
摘要 冷沉淀是FFP的部分凝血因子的浓缩制品,因其含有丰富的Ⅷ因子和纤维蛋白原,故最早用于血友病、纤维蛋白原缺乏症、XⅢ因子缺乏症等疾病的临床治疗。近年来,冷沉淀及其制剂不仅用于治疗血友病和凝血因子缺乏症,也被用于妇产科手术及其出血性疾病的防治,且效果显著。现综述冷沉淀在妇产科的应用如下。
出处 《国际检验医学杂志》 CAS 2013年第4期511-512,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献8

二级参考文献32

  • 1孙爱莲,林圣惠,盛敏,赵友冬.冷沉淀的临床应用[J].临床输血与检验,2001,3(3):70-71. 被引量:5
  • 2杨晓顺,安梅,邓淑芬,周和其,阮光萍,戴莹,王桂华.冰冻机采血小板临床应用157例结果分析[J].西南国防医药,2004,14(2):169-171. 被引量:5
  • 3安万新,马丽华,明凤琴,戴经捷,王世泰.冷沉淀治疗慢性化脓性中耳炎初探[J].中国输血杂志,1994,7(4):176-178. 被引量:2
  • 4张国山,吕秀玲,刘林,徐志华.冷沉淀用于出血性疾病的止血效果观察[J].河北医学,1996,2(5):455-456. 被引量:10
  • 5林水多.腹腔感染和不同手术创伤病例纤维结合蛋白的动态观察[J].贵州医药,1987,11(4):7-7.
  • 6肖星甫.成份输血.凝血因子缺乏的替代疗法[J].另输血,1990,3:99-99.
  • 7[1]Waumans P, Van Itterbeek R , Verstmete M . The preparation of a human plasma fraction by cryoprecipitation and its use in haemophilia[J]. Acta Clin Belg, 1968, 23(3):139-152.
  • 8[2]Silver FH, Wang MC, Pins GD. Preparation and use of fibrin glue in surgery[J]. Biomatreials, 1995, 16(12) : 891-903.
  • 9[10]Morgan MB , Truitt CA ,Taira J et al. Fibronectin and the extra-celluar matrix in the perforating disorders of the skin[J] . Am J Dermatopathol, 1998, 20(2): 147-154.
  • 10[11]Smith KJ. Preparation of pooled cryoprecipitate for treatment of hemophilia a in a home care program[J]. Transfusion , 1984, 24(6):520-523.

共引文献63

同被引文献45

  • 1王一栋,许汪斌.失血对脑创伤的影响[J].昆明医科大学学报,2009,32(S2):154-157. 被引量:1
  • 2王东伟,陈萍,陈磊.FN软膏治疗宫颈糜烂临床应用[J].黑龙江医药科学,2006,29(2):109-109. 被引量:3
  • 3周立红.冷沉淀的应用现状[J].临床血液学杂志,2004,17(1):43-44.
  • 4Herbert S, Alberto G, Christoph J, et al. Management of Hemor- rhage in Trauma [ J ]. J Cardiothorac Vasc Anesth, 2013,27 ( 4 suppl) :35-43.
  • 5Gardenfors A, Nilsson F, Skagerberg G, et al. Cerebral physiologi- cal and biochemical changes during vasogenic brain oedema in- duced by intrathecal injection of bacterial lipopolysaccharides in piglets[J]. Acta Neurochir, 2002,144(6) :601-609.
  • 6Pomper GJ, Rick ME, Epstein JS, et al. Management of severe VWD with cryoprecipitate colected by repeated apheresis of a single dedicated donor [ J ]. Transfusion, 2003,43 ( 1 1 ) : 1514.
  • 7Hornsey VS, Krailadsiri P, MacDonald S, et al. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virusin-activated plasma [ J ]. Br J Haematol, 2000,109 ( 3 ) :665.
  • 8Morrison JJ, Ross JD, Dubose JJ, et al. Association of Cryoprecip- itate and Tranexamic Acid With Improved Survival Following War- time Injury: Findings From the MATTERs II Study [ J]. JAMA Surg,2013,148 ( 3 ) :218-225.
  • 9MCVEY M,CSERTI-GAZDEWICH C M.Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HL[J].Transfus Med,2010,20:346-353.
  • 10MORRISON J J,ROSS J D,DUBOSE J J,et al.Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury:findings from the MATTERsⅡStudy[J].JAMA Surg,2013,148:218-225.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部